Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 296

1.

"Celebrating the 20th Anniversary of To Err is Human".

Cooper MR, Holmes A, Seid A, Gonzalez CE, MacDonald LQ.

Am J Med Qual. 2019 Sep/Oct;34(5):519-520. doi: 10.1177/1062860619870639. No abstract available.

PMID:
31479301
2.

A review of tobacco regulatory science research on vulnerable populations.

Higgins ST, Kurti AN, Palmer M, Tidey JW, Cepeda-Benito A, Cooper MR, Krebs NM, Baezconde-Garbanati L, Hart JL, Stanton CA.

Prev Med. 2019 May 2:105709. doi: 10.1016/j.ypmed.2019.04.024. [Epub ahead of print]

3.

Effect of hollow bit local exhaust ventilation on respirable quartz dust concentrations during concrete drilling.

Rempel D, Barr A, Cooper MR.

J Occup Environ Hyg. 2019 May;16(5):336-340. doi: 10.1080/15459624.2019.1587171. Epub 2019 Apr 23.

PMID:
31013200
4.

Pneumatic rock drill vs. electric rotary hammer drill: Productivity, vibration, dust, and noise when drilling into concrete.

Rempel D, Antonucci A, Barr A, Cooper MR, Martin B, Neitzel RL.

Appl Ergon. 2019 Jan;74:31-36. doi: 10.1016/j.apergo.2018.08.005. Epub 2018 Aug 13.

PMID:
30487106
5.

Characterizing ENDS use in young adults with ecological momentary assessment: Results from a pilot study.

Cooper MR, Case KR, Hébert ET, Vandewater EA, Raese KA, Perry CL, Businelle MS.

Addict Behav. 2019 Apr;91:30-36. doi: 10.1016/j.addbeh.2018.11.024. Epub 2018 Nov 17.

PMID:
30471788
6.

Exposure to airborne nano-titanium dioxide during airless spray painting and sanding.

West GH, Cooper MR, Burrelli LG, Dresser D, Lippy BE.

J Occup Environ Hyg. 2019 Mar;16(3):218-228. doi: 10.1080/15459624.2018.1550295. Epub 2019 Feb 12.

PMID:
30451647
7.

Hookah use as a predictor of other tobacco product use: A longitudinal analysis of Texas college students.

Case KR, Creamer MR, Cooper MR, Loukas A, Perry CL.

Addict Behav. 2018 Dec;87:131-137. doi: 10.1016/j.addbeh.2018.06.028. Epub 2018 Jun 30.

PMID:
30016762
8.

Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.

Cooper MR, Alrajhi AM, Durand CR.

Am J Ther. 2018 May/Jun;25(3):e349-e356. doi: 10.1097/MJT.0000000000000686. Review.

PMID:
29722737
9.

Does Mobile Care ('mCare') Improve Quality of Life and Treatment Satisfaction Among Service Members Rehabilitating in the Community? Results from a 36-Wk, Randomized Controlled Trial.

Little JR, Pavliscsak HH, Cooper MR, Goldstein LA, Fonda SJ.

Mil Med. 2018 Mar 1;183(3-4):e148-e156. doi: 10.1093/milmed/usx035.

PMID:
29514344
10.

E-cigarette Use and Cigarette Smoking Cessation among Texas College Students.

Mantey DS, Cooper MR, Loukas A, Perry CL.

Am J Health Behav. 2017 Nov 1;41(6):750-759. doi: 10.5993/AJHB.41.6.9.

11.

The Effects of Bit Wear on Respirable Silica Dust, Noise and Productivity: A Hammer Drill Bench Study.

Carty P, Cooper MR, Barr A, Neitzel RL, Balmes J, Rempel D.

Ann Work Expo Health. 2017 Jul 1;61(6):700-710. doi: 10.1093/annweh/wxx041.

PMID:
28595322
12.

Inhalation exposure during spray application and subsequent sanding of a wood sealant containing zinc oxide nanoparticles.

Cooper MR, West GH, Burrelli LG, Dresser D, Griffin KN, Segrave AM, Perrenoud J, Lippy BE.

J Occup Environ Hyg. 2017 Jul;14(7):510-522. doi: 10.1080/15459624.2017.1296237.

PMID:
28406371
13.

Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma.

Siu KT, Ramachandran J, Yee AJ, Eda H, Santo L, Panaroni C, Mertz JA, Sims Iii RJ, Cooper MR, Raje N.

Leukemia. 2017 Aug;31(8):1760-1769. doi: 10.1038/leu.2016.355. Epub 2016 Nov 28.

PMID:
27890933
14.

Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer.

Cooper MR, Binkowski C, Hartung J, Towle J.

Onco Targets Ther. 2016 Apr 4;9:1953-60. doi: 10.2147/OTT.S80239. eCollection 2016. Review.

15.

E-Cigarette Marketing Exposure Is Associated With E-Cigarette Use Among US Youth.

Mantey DS, Cooper MR, Clendennen SL, Pasch KE, Perry CL.

J Adolesc Health. 2016 Jun;58(6):686-90. doi: 10.1016/j.jadohealth.2016.03.003. Epub 2016 Apr 12.

16.

Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials.

Albrecht BK, Gehling VS, Hewitt MC, Vaswani RG, Côté A, Leblanc Y, Nasveschuk CG, Bellon S, Bergeron L, Campbell R, Cantone N, Cooper MR, Cummings RT, Jayaram H, Joshi S, Mertz JA, Neiss A, Normant E, O'Meara M, Pardo E, Poy F, Sandy P, Supko J, Sims RJ 3rd, Harmange JC, Taylor AM, Audia JE.

J Med Chem. 2016 Feb 25;59(4):1330-9. doi: 10.1021/acs.jmedchem.5b01882. Epub 2016 Feb 4.

PMID:
26815195
17.
18.

Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancer.

Cooper MR, Chim H, Chan H, Durand C.

Ann Pharmacother. 2015 Jan;49(1):107-12. doi: 10.1177/1060028014553619. Epub 2014 Sep 25. Review.

PMID:
25258420
19.

Stereoselective high-performance liquid chromatography and analytical method characterization of evacetrapib using a brush-type chiral stationary phase: a challenging isomeric separation requiring a unique eluent system.

Sharp VS, Stafford JD, Forbes RA, Gokey MA, Cooper MR.

J Chromatogr A. 2014 Oct 10;1363:183-90. doi: 10.1016/j.chroma.2014.03.048. Epub 2014 Mar 27.

PMID:
24725472
20.

Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer.

Patel KC, Hageman K, Cooper MR.

Am J Health Syst Pharm. 2014 Apr 1;71(7):537-48. doi: 10.2146/ajhp130342. Review.

PMID:
24644113
21.

Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patients.

Willett KC, Alsharhan M, Durand C, Cooper MR.

Ann Pharmacother. 2013 Dec;47(12):1717-20. doi: 10.1177/1060028013507902. Epub 2013 Dec 3. Review.

PMID:
24301685
22.

Vandetanib for the treatment of medullary thyroid carcinoma.

Cooper MR, Yi SY, Alghamdi W, Shaheen DJ, Steinberg M.

Ann Pharmacother. 2014 Mar;48(3):387-94. doi: 10.1177/1060028013512791. Epub 2013 Nov 14. Review.

PMID:
24259657
23.

Reversible ageusia associated with romidepsin therapy.

Cooper MR, Brewer S, Broketa G.

Am J Health Syst Pharm. 2013 Sep 1;70(17):1502-5. doi: 10.2146/130024.

PMID:
23943181
24.

The role of denosumab for prevention of skeletal-related complications in multiple myeloma.

Hageman K, Patel KC, Mace K, Cooper MR.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1069-74. doi: 10.1345/aph.1R776. Epub 2013 Jun 18. Review.

PMID:
23780806
25.

Strategies to put safety first. Adverse events, staff and patient engagement must be priorities, panelists say.

Conway W, Cooper MR, Hochberg S, McKinney M.

Mod Healthc. 2012 Jan 16;42(3):24-5. No abstract available.

PMID:
22355842
26.

Evaluation and control of respirable silica exposure during lateral drilling of concrete.

Cooper MR, Susi P, Rempel D.

J Occup Environ Hyg. 2012;9(2):D35-41. doi: 10.1080/15459624.2011.640303. No abstract available.

PMID:
22214178
27.

Mission to Mars: food production and processing for the final frontier.

Perchonok MH, Cooper MR, Catauro PM.

Annu Rev Food Sci Technol. 2012;3:311-30. doi: 10.1146/annurev-food-022811-101222. Epub 2011 Nov 28. Review.

PMID:
22136130
28.

Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.

Cooper MR, Durand CR, Beaulac MT, Steinberg M.

Ann Pharmacother. 2011 Sep;45(9):1094-102. doi: 10.1345/aph.1Q147. Epub 2011 Aug 23. Review.

PMID:
21862714
29.

In situ simulation comparing in-hospital first responder sudden cardiac arrest resuscitation using semiautomated defibrillators and automated external defibrillators.

Kobayashi L, Dunbar-Viveiros JA, Sheahan BA, Rezendes MH, Devine J, Cooper MR, Martin PB, Jay GD.

Simul Healthc. 2010 Apr;5(2):82-90. doi: 10.1097/SIH.0b013e3181ccd75c.

PMID:
20661007
30.

Comparison of sudden cardiac arrest resuscitation performance data obtained from in-hospital incident chart review and in situ high-fidelity medical simulation.

Kobayashi L, Lindquist DG, Jenouri IM, Dushay KM, Haze D, Sutton EM, Smith JL, Tubbs RJ, Overly FL, Foggle J, Dunbar-Viveiros J, Jones MS, Marcotte ST, Werner DL, Cooper MR, Martin PB, Tammaro D, Jay GD.

Resuscitation. 2010 Apr;81(4):463-71. doi: 10.1016/j.resuscitation.2010.01.003. Epub 2010 Feb 1.

PMID:
20122781
31.

The unintended consequences of being friendly: a case study.

Cooper MR, Duquette CE, McWilliams T, Orsini M, Klein AA.

J Healthc Qual. 2009 Sep-Oct;31(5):43-7.

PMID:
19813560
32.

Engineering control technologies to reduce occupational silica exposures in masonry cutting and tuckpointing.

Meeker JD, Cooper MR, Lefkowitz D, Susi P.

Public Health Rep. 2009 Jul-Aug;124 Suppl 1:101-11.

33.

Efficacy and safety of modafinil in the treatment of cancer-related fatigue.

Cooper MR, Bird HM, Steinberg M.

Ann Pharmacother. 2009 Apr;43(4):721-5. doi: 10.1345/aph.1L532. Epub 2009 Mar 24. Review.

PMID:
19318599
34.

Effect of computer order entry on prevention of serious medication errors in hospitalized children.

Walsh KE, Landrigan CP, Adams WG, Vinci RJ, Chessare JB, Cooper MR, Hebert PM, Schainker EG, McLaughlin TJ, Bauchner H.

Pediatrics. 2008 Mar;121(3):e421-7. doi: 10.1542/peds.2007-0220.

PMID:
18310162
35.

Clinically relevant QTc prolongation is not associated with current dose schedules of LBH589 (panobinostat).

Zhang L, Lebwohl D, Masson E, Laird G, Cooper MR, Prince HM.

J Clin Oncol. 2008 Jan 10;26(2):332-3; discussion 333-4. doi: 10.1200/JCO.2007.14.7249. No abstract available. Erratum in: J Clin Oncol.2008 Apr 20;26(12):2066.

PMID:
18182676
36.

Improving colorectal cancer screening by using community volunteers: results of the Carolinas cancer education and screening (CARES) project.

Katz ML, Tatum C, Dickinson SL, Murray DM, Long-Foley K, Cooper MR, Daven M, Paskett ED.

Cancer. 2007 Oct 1;110(7):1602-10.

37.

Medication errors related to computerized order entry for children.

Walsh KE, Adams WG, Bauchner H, Vinci RJ, Chessare JB, Cooper MR, Hebert PM, Schainker EG, Landrigan CP.

Pediatrics. 2006 Nov;118(5):1872-9.

PMID:
17079557
38.

Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics.

DeAngelo DJ, Stone RM, Heaney ML, Nimer SD, Paquette RL, Klisovic RB, Caligiuri MA, Cooper MR, Lecerf JM, Karol MD, Sheng S, Holford N, Curtin PT, Druker BJ, Heinrich MC.

Blood. 2006 Dec 1;108(12):3674-81. Epub 2006 Aug 10.

39.

Medication safety--reliability of preference cards.

Dawson A, Orsini MJ, Cooper MR, Wollenburg K.

AORN J. 2005 Sep;82(3):399, 401-4, 406-7 passim.

PMID:
16309067
40.

NewYork-Presbyterian Hospital: translating innovation into practice.

Johnson T, Currie G, Keill P, Corwin SJ, Pardes H, Cooper MR.

Jt Comm J Qual Patient Saf. 2005 Oct;31(10):554-60.

PMID:
16294667
41.

Model for a merger: New York-Presbyterian's use of service lines to bring two academic medical centers together.

Corwin SJ, Cooper MR, Leiman JM, Stein DE, Pardes H, Berman MA.

Acad Med. 2003 Nov;78(11):1114-20.

PMID:
14604869
42.

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Parnes HL, Cirrincione C, Aisner J, Berry DA, Allen SL, Abrams J, Chuang E, Cooper MR, Perry MC, Duggan DB, Szatrowski TP, Henderson IC, Norton L; Cancer and Leukemia Group B.

J Clin Oncol. 2003 May 1;21(9):1819-24.

PMID:
12721259
43.

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L.

J Clin Oncol. 2003 Mar 15;21(6):976-83.

PMID:
12637460
44.

Impact of a computerized alert during physician order entry on medication dosing in patients with renal impairment.

Oppenheim MI, Vidal C, Velasco FT, Boyer AG, Cooper MR, Hayes JG, Frayer WW.

Proc AMIA Symp. 2002:577-81.

45.

Medicine at the medical center then and now: one hundred years of progress.

Cooper MR, Stewart DC, Kahl FR, Brown WM, Cordell AR.

South Med J. 2002 Oct;95(10):1113-21.

PMID:
12425493
46.

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

Rai KR, Freter CE, Mercier RJ, Cooper MR, Mitchell BS, Stadtmauer EA, Santábarbara P, Wacker B, Brettman L.

J Clin Oncol. 2002 Sep 15;20(18):3891-7.

PMID:
12228210
47.
48.

Clinical trial enrollment of rural patients with cancer.

Paskett ED, Cooper MR, Stark N, Ricketts TC, Tropman S, Hatzell T, Aldrich T, Atkins J.

Cancer Pract. 2002 Jan-Feb;10(1):28-35.

PMID:
11866706
49.

Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina.

Stark N, Paskett E, Bell R, Cooper MR, Walker E, Wilson A, Tatum C.

J Natl Med Assoc. 2002 Jan;94(1):31-9. Review.

50.

Cancer control and the Central Cancer Registry of North Carolina.

Cooper MR, Herman D, Aldrich TE.

N C Med J. 2001 Sep-Oct;62(5):308-10. No abstract available.

PMID:
11570332

Supplemental Content

Loading ...
Support Center